Global Exoskeleton Market Size (2024 - 2029)

The exoskeleton market is experiencing significant growth, driven by an increasing demand for robotic rehabilitation devices due to the rising prevalence of disabilities and an aging global population. The market's expansion is further supported by the growing adoption of exoskeletons in healthcare, particularly for rehabilitation purposes, as they help alleviate the burden on physiotherapy staff and enhance patient care. The COVID-19 pandemic initially caused a setback, but the demand surged as exoskeletons proved beneficial in managing patient care challenges. Innovations and collaborations among key players are also contributing to the market's upward trajectory, as they introduce advanced technologies to support rehabilitation efforts.

Market Size of Global Exoskeleton Industry

Exoskeleton Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 0.82 Billion
Market Size (2029) USD 2.79 Billion
CAGR (2024 - 2029) 15.32 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Exoskeleton Market Major Players

*Disclaimer: Major Players sorted in no particular order

Exoskeleton Market Analysis

The Global Exoskeleton Market size is estimated at USD 0.82 billion in 2024, and is expected to reach USD 2.79 billion by 2029, growing at a CAGR of 15.32% during the forecast period (2024-2029).

The major factors propelling the market’s growth are the high burden of stroke, the increasing adoption of exoskeletons, and the growing geriatric population. With the increasing number of disabled and aged people, the demand for robotic rehabilitation is rising globally.

In recent years, the demand for physical therapy services has grown, partly because of the aging population. The role of technology in healthcare has become evident with the enhanced rate of survival from medical disorders such as stroke. Robotic rehabilitation and assistive technologies ease the stress on the physiotherapy staff and control expenses while refining patients’ quality of life.

The higher burden of musculoskeletal injuries, mainly spinal cord injuries, is projected to augment the adoption of exoskeleton systems as a rehabilitation system after spinal cord injuries. For instance, according to a May 2023 report of Spinal Cord Inc., around 18,000 spinal cord injuries (SCI) were reported every year in the United States, with an annual incidence rate of 54 per 1 million. Similarly, according to an article published by Springer Nature in November 2023, the burden of spondylodiscitis increased in Germany over the years and is more prevalent in the elderly population. Thus, the exaggerated burden of spinal cord injuries is likely to present lucrative growth opportunities for exoskeleton systems to offer ergonomic support for the body, which is anticipated to boost market growth over the forecast period.

The proven role of modern exoskeleton systems in the rehabilitation of spinal cord injuries is another factor projected to boost market growth over the forecast period. According to an article published by the Journal of Neuro Engineering and Rehabilitation in March 2023, the adoption of exoskeleton systems in clinical settings is safe and well-tolerated by patients, and patients receiving exoskeleton systems as a rehabilitation therapy after spinal cord injuries reported walking independence with these systems. Thus, the profound role of these systems is projected to boost their adoption over the coming years.

Innovations through key market players and increasing regulatory sanctions are also projected to foster market expansion. For instance, in October 2022, Kenoteq, a Heriot-Watt spin-out company, participated in a trial to test the capacity of exoskeleton suits in a factory environment.

In addition, in April 2023, Harmonic Bionics launched its flagship exoskeleton, Harmony SHR, following registration with the US FDA. Thus, such participations are poised to offer significant promise for the development of advanced exoskeleton systems, which is expected to boost market growth over the forecast period.

Thus, growing demand from the healthcare sector for robotic rehabilitation, high incidence of spinal cord injuries, advancement in robotic technologies, and huge investments in the development of exoskeleton technology are expected to drive market growth over the forecast period. However, the risks involved in using exoskeletons due to vague safety guidelines may slow down the growth.

Exoskeleton Industry Segmentation

As per the scope of the report, exoskeletons are the external skeletons that support and protect the body in contrast to the internal skeleton (endoskeleton). These are wearable machines that enable limb movement with amplified strength and enhance the performance of human tasks.

The exoskeleton market is segmented by treatment type, body part type, product type, and geography. By treatment type, the market is segmented into rehabilitation and augmentation. By body part type, the market is segmented into upper body and lower body. By product type, the market is segmented into stationary and mobile. The report also covers the market sizes and forecasts in major countries across different regions. For each segment, the market size is provided in terms of value (USD).

By Treatment Type
Rehabilitation
Augmentation
By Body Part Type
Upper Body
Lower Body
By Product Type
Stationary
Mobile
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Exoskeleton Market Size Summary

The exoskeleton market is poised for significant growth, driven by the increasing prevalence of disabilities and the aging global population. The demand for robotic rehabilitation devices is on the rise as these technologies offer promising solutions for improving the quality of life for individuals with movement disorders. The market is experiencing a surge in interest due to the growing adoption of exoskeletons in healthcare settings, particularly for stroke rehabilitation and support for geriatric patients. The COVID-19 pandemic highlighted the utility of exoskeletons in medical settings, as they were used to assist healthcare workers and patients with mobility challenges. This has led to a renewed focus on the development and deployment of these technologies in rehabilitation programs worldwide.

North America holds a significant share of the exoskeleton market, supported by high purchasing power, a robust geriatric population, and substantial investments in research and development. Key market players, including Cyberdyne, Ekso Bionics Holdings, Rewalk Robotics, and Bionik Laboratories, are actively investing in innovative product development and seeking regulatory approvals to enhance their market presence. The market's growth is further bolstered by strategic partnerships and collaborations aimed at integrating exoskeleton technology into rehabilitation practices. As the demand for advanced rehabilitation solutions continues to rise, the exoskeleton market is expected to expand, offering new opportunities for both patients and healthcare providers.

Explore More

Global Exoskeleton Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Demand from Healthcare Sector for Robotic Rehabilitation

      2. 1.2.2 Advancement in Robotic Technologies

      3. 1.2.3 Growing Burden of Musculoskeletal Disorders

    3. 1.3 Market Restraints

      1. 1.3.1 Risks Involved with Using Exoskeletons Due to Vague Safety Guidelines

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 2.1 By Treatment Type

      1. 2.1.1 Rehabilitation

      2. 2.1.2 Augmentation

    2. 2.2 By Body Part Type

      1. 2.2.1 Upper Body

      2. 2.2.2 Lower Body

    3. 2.3 By Product Type

      1. 2.3.1 Stationary

      2. 2.3.2 Mobile

    4. 2.4 By Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global Exoskeleton Market Size FAQs

The Global Exoskeleton Market size is expected to reach USD 0.82 billion in 2024 and grow at a CAGR of 15.32% to reach USD 2.79 billion by 2029.

In 2024, the Global Exoskeleton Market size is expected to reach USD 0.82 billion.

Exoskeleton Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)